Small Cap Stocks In News: Ariad Pharmaceuticals (NASDAQ:ARIA), Scientific Games Corp (NASDAQ:SGMS), FuelCell Energy (NASDAQ:FCEL), Plug Power (NASDAQ:PLUG)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it will report its first quarter 2014 financial results on Wednesday May 7 2014 before the market opens. Following the announcement at 8:30 a.m. Eastern Time company management will host a conference call and webcast discussion of the results and provide a general corporate update. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was 1.48% in last session and finished the … Continue reading Small Cap Stocks In News: Ariad Pharmaceuticals (NASDAQ:ARIA), Scientific Games Corp (NASDAQ:SGMS), FuelCell Energy (NASDAQ:FCEL), Plug Power (NASDAQ:PLUG)

Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Johnson & Johnson (NYSE:JNJ)

A proxy advisory firm has asked shareholders of the Indian unit of Wyeth to oppose its merger deal with Pfizer Inc. (NYSE:PFE) as the share swap ratio is skewed in favour of Pfizer Inc. (NYSE:PFE). Shareholder Empowerment Services (SES) has made this suggestion ahead of the shareholder meeting this week. Pfizer Inc. (NYSE:PFE) stock performance was 0.07% in last session and finished the day at … Continue reading Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Johnson & Johnson (NYSE:JNJ)

Finally, Zacks upgraded shares of Plug Power Inc (NASDAQ:PLUG) from a neutral rating to an outperform rating. Zacks now has a $7.90 price target on that stock. Plug Power Inc (NASDAQ:PLUG) stock performance was -4.51% in last session and finished the day at $6.99. Traded volume was 23.45million shares in the last session and the average volume of the stock remained 44.53million shares. The beta … Continue reading NASDAQ Volatile Stocks: Plug Power Inc (NASDAQ:PLUG), Wave Systems (NASDAQ:WAVX), Ariad Pharmaceuticals (NASDAQ:ARIA), Galena Biopharma (NASDAQ:GALE)

Amgen Inc. (NASDAQ:AMGN) carries a Zacks Rank #1 (Strong Buy). Amgen, Inc. (NASDAQ:AMGN) stock performance was -1.90% in last session and finished the day at $111.94. Traded volume was 7.26million shares in the last session and the average volume of the stock remained 3.63million shares. The beta of the stock remained 0.51. Amgen, Inc. (NASDAQ:AMGN) insider ownership is 0.10%. Novavax, Inc. (NASDAQ:NVAX), a clinical-stage biopharmaceutical … Continue reading Health Stocks In New: Amgen (NASDAQ:AMGN), Novavax (NASDAQ:NVAX), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

The appointment of Hugh M. Cole as the Senior Vice President as well as Chief Business Officer of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has been announced. He would be reporting to Chairman as well as CEO Harvey J. Berger. Cole, who has more than 25 years of experience in the pharma industry, would take up the strategic planning as well as the business development of the … Continue reading Small Cap Active Runners: Ariad Pharmaceuticals (NASDAQ:ARIA), FuelCell Energy Inc (NASDAQ:FCEL), IAMGOLD (NYSE:IAG), E Commerce China Dangdang (NYSE:DANG)

Sales of the Arena Pharmaceuticals Inc (NASDAQ:ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note. Sales improved throughout the quarter and are pacing well ahead of the previous quarter. Though this week’s sales only take us to March 28th, there is enough here for us to assess the sales activity, project some revenue, and look to the pace. Arena Pharmaceuticals, Inc. … Continue reading Biotech Active runners: Arena Pharmaceuticals (NASDAQ:ARNA), Halozyme Therapeutics (NASDAQ:HALO), Gildan Activewear (NYSE:GIL), Ariad Pharmaceuticals (NASDAQ:ARIA)